Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis
Clinical trial NCT01926028 · COMPLETED
Trial details
- NCT number
- NCT01926028
- Sponsor
- NovaDigm Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2015-05-01
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.